**Core Concept:** Selective beta-2 blockers are a class of medications that primarily target beta-2 receptors, inhibiting the effects of catecholamines, particularly epinephrine and norepinephrine. They are used for various cardiovascular conditions, such as asthma and chronic obstructive pulmonary disease (COPD).

**Why the Correct Answer is Right:** Salbutamol (A), also known as albuterol, is a selective beta-2 blocker due to its high affinity for beta-2 receptors, which results in bronchodilation (relaxation of airway smooth muscle) and increased bronchoprovocation sensitivity in asthma patients. Salbutamol does not significantly inhibit beta-1 receptors, which helps preserve cardiac function. This makes it a selective beta-2 agonist.

**Why Each Wrong Option is Incorrect:**

A. Salmeterol (B) is another selective beta-2 agonist, but with a longer duration of action due to its lipophilic nature. However, it is not a blocker like salbutamol.

C. Propranolol (C) is a non-selective beta-blocker, meaning it inhibits beta-1 receptors as well as beta-2 receptors. This leads to undesirable side effects like bradycardia, hypotension, and bronchospasm in asthmatic patients.

D. Attenuation of sympathetic activity (D) is the general mechanism of action for beta-blockers, but the distinction between selective and non-selective blockers is crucial. Salbutamol is a selective beta-2 blocker, whereas propranolol is a non-selective beta-blocker.

**Clinical Pearl:** Selective beta-2 blockers like salbutamol are crucial in the management of asthma, as they primarily act on airway smooth muscle, improving bronchodilation without significant cardiac side effects. In contrast, non-selective beta-blockers like propranolol can worsen the condition by blocking beta-2 receptors and leading to bronchoconstriction.